| Patient | Harriet Tubman |
|---|---|
| Date of birth | 1951-03-01 |
| Identifiers | MRN HR-NI005-SYN; SSN (made up) 000-05-3961 |
| Document date | 2026-04-06 |
| Author | Carmen Ruiz-Delgado, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit for lifelong headaches and sudden sleep spells [S]
This fictional modern episode addresses the presenting concerns below. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
1 later historical claim is omitted because it describes events after the index age. See the teaching note.
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| Mid-1830s, at about age 13 | Head injury in her early teens from an iron weight thrown by an overseer; nearly killed, with little or no medical care | D (CLM-0003) |
| From the mid-1830s onward | Headaches and sudden spells of sleep with vivid dreams and visions since the injury, continuing into old age | D (CLM-0004) |
| Retrospective proposal | Temporal lobe epilepsy proposed retrospectively as the cause of the spells; not established | R (CLM-0005) |
| Retrospective proposal, 2023 | Post-traumatic narcolepsy proposed retrospectively in 2023 as an alternative explanation; not established | R (CLM-0006) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Ibuprofen 200 mg oral tablet, two tablets by mouth most days (self-directed, over the counter) | Two tablets by mouth most days | Oral route | 2025-09-01 to 2026-04-06 | stopped | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth as needed for headache, no more than 2 days a week | Two tablets by mouth as needed, at most 2 days a week | Oral route | 2026-04-06 | active | S |
Positive for the concerns in the history of present illness. Alert between episodes, oriented, and direct; resumes conversation where she left off after a spell; MoCA 26. Mood steady; PHQ-9, GAD-7, and PC-PTSD-5 below their thresholds. No other systems reported as affected in this synthetic episode. [S]
Alert and engaged. Independent in all activities of daily living; falls asleep without warning several times a day, including mid-conversation and at meetings. Headaches stop household work about two days a week at intake. [S]
Vital signs recorded on 2026-04-06; see the Vital Signs section. Mental status: Alert between episodes, oriented, and direct; resumes conversation where she left off after a spell; MoCA 26; Mood steady; PHQ-9, GAD-7, and PC-PTSD-5 below their thresholds. The physical examination is limited to the findings relevant to this synthetic episode. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-04-06 | Body height | 152 | cm | S |
| 2026-04-06 | Body weight | 52 | kg | S |
| 2026-04-06 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 2026-04-06 | Systolic blood pressure | 146 | mm[Hg] | S |
| 2026-04-06 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 2026-04-06 | Heart rate | 72 | /min | S |
| 2026-04-06 | Respiratory rate | 14 | /min | S |
| 2026-04-06 | Body temperature | 36.6 | Cel | S |
| 2026-04-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-06 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-04-06 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-04-06 | Creatinine [Mass/volume] in Serum or Plasma | 0.84 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-04-06 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 72 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-04-06 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-04-06 | Hemoglobin [Mass/volume] in Blood | 12.6 | g/dL | 11.6-15 g/dL | Normal | S |
| 2026-04-06 | Ferritin [Mass/volume] in Serum or Plasma | 88 | ng/mL | 30-400 ng/mL | Normal | S |
| 2026-04-06 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-04-06 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 410 | pg/mL | 232-1245 pg/mL | Normal | S |
| 2026-04-06 | PROMIS sleep related impairment - version 1.0 Tscore | 68 | {score} | S | ||
| 2026-04-06 | On how many days in the last 3 months did you have a headache, if headache lasted more than 1 day, count each day [PhenX] | 54 | {days} | S | ||
| 2026-04-06 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-04-06 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | {score} | S | ||
| 2026-04-06 | PC-PTSD-5 score [PC-PTSD-5] | 2 | {score} | S | ||
| 2026-04-06 | Total score [MoCA] | 26 | {score} | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Chronic post-traumatic headache since an adolescent head injury | active | confirmed | G44.329 | S — Synthetic modern coding of the documented lifelong headaches. |
| Medication-overuse headache from near-daily ibuprofen, resolved after withdrawal | resolved | confirmed | G44.40 | S — Synthetic finding; resolved by the three-month review. |
| Sequelae of a traumatic brain injury in adolescence, a skull fracture by historical account | active | confirmed | S06.9XAS | S — Synthetic modern coding of the documented injury; the MRI findings in the episode are synthetic. |